These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pharmacokinetics of endotoxin in a rhesus macaque septic shock model. Premaratne S; May ML; Nakasone CK; McNamara JJ J Surg Res; 1995 Oct; 59(4):428-32. PubMed ID: 7564312 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of therapeutic agents: morphologic changes and survival data in dogs subjected to endotoxin during the shock tour. Brunson JG; Schulz DM; Angevine DM; Imrie ST; Douglas BH J Okla State Med Assoc; 1966 Aug; 59(8):477-84. PubMed ID: 5944537 [No Abstract] [Full Text] [Related]
24. Preventive effects of a biscoclaurine alkaloid, cepharanthine, on endotoxin or tumor necrosis factor-alpha-induced septic shock symptoms: involvement of from cell death in L929 cells and nitric oxide production in raw 264.7 cells. Sakaguchi S; Furusawa S; Wu J; Nagata K Int Immunopharmacol; 2007 Feb; 7(2):191-7. PubMed ID: 17178386 [TBL] [Abstract][Full Text] [Related]
25. Endotoxin shock in the geriatric patient. Oaks WW; Cohen HE Geriatrics; 1967 Mar; 22(3):120-30. PubMed ID: 5335496 [No Abstract] [Full Text] [Related]
27. Aspects of plasma proteolysis in lethal canine endotoxin shock. Aasen AO; Amundsen E Acta Chir Scand Suppl; 1982; 509():23-31. PubMed ID: 6762028 [TBL] [Abstract][Full Text] [Related]
28. J5 prevents endotoxin shock in suckling rats. Yoshioka T; Goto M; Kodama M; Gottschalk ME; Anderson CL; Young MR; Zeller WP Res Commun Chem Pathol Pharmacol; 1993 Jun; 80(3):367-70. PubMed ID: 8351416 [TBL] [Abstract][Full Text] [Related]
29. Role of angiotensin I and glucagon in canine endotoxin shock: effect of converting enzyme inhibitor and prior immunization. Manson NH; Hess ML Circ Shock; 1984; 12(3):177-89. PubMed ID: 6325034 [TBL] [Abstract][Full Text] [Related]
30. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs. Fletcher JR; Ramwell PW Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660 [TBL] [Abstract][Full Text] [Related]
31. Endotoxin, tumor necrosis factor, and related mediators: new approaches to shock. Beutler B New Horiz; 1993 Feb; 1(1):3-12. PubMed ID: 7922391 [TBL] [Abstract][Full Text] [Related]
32. Current management of the septic shock patient: experimental basis for treatment. Hinshaw LB; Beller-Todd BK; Archer LT Circ Shock; 1982; 9(5):543-53. PubMed ID: 6756669 [TBL] [Abstract][Full Text] [Related]
34. Role of the spleen and portal hypertension in canine endotoxin shock. Boruchow IB; Abel RM Surgery; 1966 Dec; 60(6):1195-202. PubMed ID: 5332809 [No Abstract] [Full Text] [Related]
36. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Kojika M; Sato N; Yaegashi Y; Suzuki Y; Suzuki K; Nakae H; Endo S Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131 [TBL] [Abstract][Full Text] [Related]
37. Microcirculation in endotoxin shock. Bains JW; Bond TP; Lewis SR Surg Forum; 1965; 16():484-5. PubMed ID: 5319690 [No Abstract] [Full Text] [Related]
38. Use of isoproterenol and phenoxybenzamine in treatment of endotoxin shock. Vick JA; Ciuchta HP; Manthei JH J Pharmacol Exp Ther; 1965 Dec; 150(3):382-8. PubMed ID: 5852873 [No Abstract] [Full Text] [Related]
39. The influence of pancreatic duct ligation on the course of E. coli endotoxin shock in the dog. De Koos EB; Gibson WJ; Bounous G; Hampson LG Can J Surg; 1966 Jul; 9(3):227-30. PubMed ID: 5328814 [No Abstract] [Full Text] [Related]